BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15848607)

  • 61. Risk factors that can influence kidney transplant outcome.
    Parzanese I; Maccarone D; Caniglia L; Pisani F; Mazzotta C; Rizza V; Famulari A
    Transplant Proc; 2006 May; 38(4):1022-3. PubMed ID: 16757251
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The initiation of erythropoiesis following renal transplantation.
    Brown JH; Lappin TR; Elder GE; Taylor TN; Bridges JM; McGeown MG
    Nephrol Dial Transplant; 1989; 4(12):1076-9. PubMed ID: 2517329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The first year renal function as a predictor of long-term graft survival after kidney transplantation.
    Helal I; Abderrahim E; Ben Hamida F; Ounissi M; Essine S; Hedri H; Bardi R; Elgorgi Y; El Younsi F; Ben Maiz H; Ben Abdallah T; Kheder A
    Transplant Proc; 2009 Mar; 41(2):648-50. PubMed ID: 19328945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients.
    Moore J; He X; Cockwell P; Little MA; Johnston A; Borrows R
    Transplantation; 2008 Aug; 86(4):564-70. PubMed ID: 18724227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
    Boratynska M; Banasik M; Patrzalek D; Klinger M
    Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
    Johnston O; O'kelly P; Spencer S; Donohoe J; Walshe JJ; Little DM; Hickey D; Conlon PJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Posttransplantation glomerulonephritis: risk factors associated with kidney allograft loss.
    Ostrowska J; Pazik J; Lewandowski Z; Mróz A; Perkowska-Ptasińska A; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2751-3. PubMed ID: 18021977
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium.
    Augustine JJ; Rodriguez V; Padiyar A; Bodziak KA; Schulak JA; Hricik DE
    Transplantation; 2008 Aug; 86(4):548-53. PubMed ID: 18724224
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J; López-Gómez JM; Aljama P
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk factors and prognosis for proteinuria in renal transplant recipients.
    Sancho A; Gavela E; Avila A; Morales A; Fernández-Nájera JE; Crespo JF; Pallardo LM
    Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anemia identified one month after renal transplantation is predictive of anemia identified after twelve months.
    Imamović G; Zerem E; Omerović S
    Bosn J Basic Med Sci; 2009 Aug; 9(3):221-4. PubMed ID: 19754477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients.
    Yorgin PD; Belson A; Sanchez J; Al Uzri AY; Sarwal M; Bloch DA; Oehlert J; Salvatierra O; Alexander SR
    Am J Kidney Dis; 2002 Dec; 40(6):1306-18. PubMed ID: 12460052
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anemia after kidney transplantation in adult recipients: prevalence and risk factors.
    Einollahi B; Lessan-Pezeshki M; Rostami Z; Kalantar E; Afshar R; Beiraghdar F
    Transplant Proc; 2011 Mar; 43(2):578-80. PubMed ID: 21440766
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The possible role of early post-transplant inflammation in later anemia in kidney transplant recipients.
    Imamović G; Zerem E; Omerović S; Osmanović E; Hodzić E
    Bosn J Basic Med Sci; 2009 Nov; 9(4):307-12. PubMed ID: 20001997
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anemia and erythrocytosis in patients after kidney transplantation.
    Malyszko J; Oberbauer R; Watschinger B
    Transpl Int; 2012 Oct; 25(10):1013-23. PubMed ID: 22716097
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Posttransplantation anemia in kidney transplant recipients: A retrospective cohort study.
    Gafter-Gvili A; Ayalon-Dangur I; Cooper L; Shochat T; Rahamimov R; Gafter U; Mor E; Grossman A
    Medicine (Baltimore); 2017 Aug; 96(32):e7735. PubMed ID: 28796058
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors associated with anaemia in kidney transplant recipients in the first year after transplantation: a cross-sectional study.
    Lim AKH; Kansal A; Kanellis J
    BMC Nephrol; 2018 Oct; 19(1):252. PubMed ID: 30290796
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anemia and Erythrocytes: Behavior and Prevalence 1 Year After Kidney Transplant.
    Rosales Morales KB; Pérez RE; Cancino López JD; Díaz ER; Chacón Pérez MJ; Zavalza Camberos PA; Cheng MDCA; Cedillo Galindo HA; Morinelli Astorquizaga MA; Trejo Villeda LEM; Sierra RP; Hernández Rivera JCH
    Transplant Proc; 2020 May; 52(4):1169-1172. PubMed ID: 32164957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.